Hospital For Special Surgery ( Site 4020) — New York, New York

Hospital For Special Surgery ( Site 4020) is a clinical research site located in New York, New York, United States 10021.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Hospital For Special Surgery ( Site 4020) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Diffuse Cutaneous Systemic Sclerosis, Interstitial Lung Disease.

Sponsors: Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA).

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hospital For Special Surgery ( Site 4020)?

Hospital For Special Surgery ( Site 4020) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hospital For Special Surgery ( Site 4020) conducted?

Hospital For Special Surgery ( Site 4020) has 1 clinical trials on record, with 1 currently active. Their work covers Diffuse Cutaneous Systemic Sclerosis, Interstitial Lung Disease.

Is Hospital For Special Surgery ( Site 4020) accredited by Crixeo Health?

Hospital For Special Surgery ( Site 4020) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Hospital For Special Surgery ( Site 4020)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.